Quest Diagnostics, San Juan Capistrano, CA, USA.
Quest Diagnostics, San Juan Capistrano, CA, USA.
Atherosclerosis. 2017 Aug;263:287-292. doi: 10.1016/j.atherosclerosis.2017.07.003. Epub 2017 Jul 5.
After assessing the risk for cardiovascular disease (CVD) based on traditional risk factors, decisions concerning lipid lowering therapy might remain uncertain. To investigate whether lipoprotein subfraction levels could aid these decisions, we assessed the association between lipoprotein subfractions and CVD, after adjustment for traditional risk factors including standard lipids.
Using a case-cohort design, participants were randomly drawn from the Malmö Prevention Project (MPP), a population-based prospective study of 18,240 participants, and supplemented with additional incident CVD events (5764 participants, 1784 CVD events).
Low density lipoprotein particle number (LDL-P) and individual subfractions ranging in size from very-small to large were associated with CVD (continuous p value (p) < 0.001) while adjusting for age, sex, hypertension, smoking, and diabetes. After further adjustment for LDL-C, HDL-C, and triglycerides, very small LDL subfraction (b) (LDL-VS (b)) remained associated with CVD (HR = 1.23, 95% CI, 1.06 to 1.43 for top vs. bottom quartile, p = 0.03). Among participants with low/intermediate risk [without diabetes and with LDL-C <3.36 mmol/L (<130 mg/dL)], the fully adjusted HR for LDL-small (top vs. bottom quartile) was 1.48 (95% CI 1.02 to 2.17, p = 0.03). Among those with very-high risk (>20% 10-year risk of CVD), LDL-VS(a) and LDL-VS(b) were associated with CVD in fully adjusted models (HR = 1.37, 95% CI 1.12 to 1.67 and HR = 1.28, 95% CI 1.07 to 1.53, respectively, p≤0.03).
Smaller LDL particles are associated with incident CVD independently of traditional risk factors, including standard lipids, in participants with low/intermediate and very-high risk, who might benefit from improved risk assessment.
在基于传统危险因素评估心血管疾病(CVD)风险后,有关降脂治疗的决策可能仍存在不确定性。为了探讨脂蛋白亚组分水平是否有助于这些决策,我们在调整包括标准脂质在内的传统危险因素后,评估了脂蛋白亚组分与 CVD 之间的关系。
使用病例-队列设计,从基于人群的前瞻性研究 Malmö 预防项目(MPP)中随机抽取参与者(18240 名参与者),并补充了其他 CVD 事件(5764 名参与者,1784 例 CVD 事件)。
在调整年龄、性别、高血压、吸烟和糖尿病后,低密度脂蛋白颗粒数(LDL-P)和从小到大都有大小的个体亚组分与 CVD 相关(连续 p 值(p)<0.001)。在进一步调整 LDL-C、HDL-C 和甘油三酯后,非常小的 LDL 亚组分(b)(LDL-VS(b))仍然与 CVD 相关(HR=1.23,95%CI,顶部与底部四分位的 1.06 至 1.43,p=0.03)。在低/中危[无糖尿病且 LDL-C<3.36mmol/L(<130mg/dL)]的参与者中,LDL-小(顶部与底部四分位)的全调整 HR 为 1.48(95%CI 1.02 至 2.17,p=0.03)。在极高危(>20%的 CVD 10 年风险)人群中,LDL-VS(a)和 LDL-VS(b)在全调整模型中与 CVD 相关(HR=1.37,95%CI 1.12 至 1.67 和 HR=1.28,95%CI 1.07 至 1.53,分别为 p≤0.03)。
在低/中危和极高危参与者中,较小的 LDL 颗粒与 CVD 事件独立于传统危险因素相关,包括标准脂质,这些参与者可能受益于风险评估的改善。